These data are corroborated by other analyses of the mediators released: in macrophages exposed to tumor cells or the tumor ECM higher levels of IL-6, IL-10, TGF-β, CCL17, CCL18, and CCL22 were detected. This evidence concerns the gene CCL22 and neoplasm.